CIB IFRS Consolidated Financial Statements FY25
Source: RNS| http://www.rns-pdf.londonstockexchange.com/rns/3239S_1-2026-2-9.pdf |
||||||||
|
|
|
|
|
|
|
|
||
|
Consolidated Income Statement for the Year Ended December 31, 2025 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Notes |
Dec. 31, 2025 |
|
|
Dec. 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest revenue calculated using the effective interest method other interest and similar income |
|
211,600,177 |
|
|
182,735,474 |
|
|
|
|
Interest expense calculated using the effective interest method other interest and similar expense |
|
(104,121,746) |
|
|
(91,751,450) |
|
|
|
|
Net interest income |
3 |
107,478,431 |
|
|
90,984,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fee and commission income |
|
16,036,009 |
|
|
12,813,876 |
|
|
|
|
Fee and commission expense |
|
(6,816,966) |
|
|
(5,728,656) |
|
|
|
|
Net fee and commission income |
4 |
9,219,043 |
|
|
7,085,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend income |
5 |
216,273 |
|
|
195,047 |
|
|
|
|
Net trading income |
6 |
1,523,649 |
|
|
20,470,230 |
|
|
|
|
Gain on investments |
21 |
775,841 |
|
|
459,337 |
|
|
|
|
Administrative expenses |
7 |
(24,692,107) |
|
|
(19,952,958) |
|
|
|
|
Other operating income (expenses) |
8 |
(1,533,040) |
|
|
(22,323,778) |
|
|
|
|
Net impairment Released (charge) |
9 |
11,804,786 |
|
|
(5,401,308) |
|
|
|
|
Bank's share in the profit and (loss) of associates |
12 |
10,512 |
|
|
(17,786) |
|
|
|
|
Profit before income tax from continuing operations |
|
104,803,388 |
|
|
71,498,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
10 |
(29,323,206) |
|
|
(21,878,946) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit for the year |
|
75,480,182 |
|
|
49,619,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
|
|
|
|
Equity holders of the parent |
|
75,460,219 |
|
|
49,558,744 |
|
|
|
|
Non-controlling interest |
|
19,963 |
|
|
60,338 |
|
|
|
|
Net profit for the year |
|
75,480,182 |
|
|
49,619,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share |
11 |
|
|
|
|
|
|
|
|
Basic earnings per share |
|
22.34 |
|
|
14.67 |
|
|
|
|
Diluted earnings per share |
|
22.10 |
|
|
14.51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements. |
|
|
|
|
||||
|
Refer note 45 for changes to comparative figures. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Islam Zekry |
|
Hisham Ezz Al-Arab |
|
|
|
|||
|
Group CFO & Executive Board Member |
|
CEO & Executive Board Member |
|
|
|
|||
|
9-Feb-2026 |
|
9-Feb-2026 |
|
|
|
|||
|
|
|
|
|
|
|
|
|||||||
|
Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2025 |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
Dec. 31, 2025 |
|
|
Dec. 31, 2024 |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Profit for the year |
|
75,480,182 |
|
|
49,619,082 |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Other comprehensive income that will not be reclassified to the income statement: |
|
|
|
|
|
|
|
|
|||||
|
Change in fair value of equity instruments measured at fair value through comprehensive income |
|
503,643 |
|
|
473,294 |
|
|
|
|||||
|
Deferred Tax impact for investments that will not be reclassified to P&L |
|
(96,248) |
|
|
(15,674) |
|
|
|
|||||
|
Other comprehensive income that will be reclassified to the income statement: |
|
|
|
|
|
|
|
|
|||||
|
Change in fair value of financial assets measured at fair value through comprehensive income |
|
10,758,425 |
|
|
9,242,129 |
|
|
|
|||||
|
Reclassification to consolidated income statement |
|
(498,433) |
|
|
(459,337) |
|
|
|
|||||
|
Cumulative foreign currencies translation differences |
|
(295,691) |
|
|
989,367 |
|
|
|
|||||
|
Deferred Tax impact for investments that may be reclassified to P&L |
|
(615,506) |
|
|
(654,214) |
|
|
|
|||||
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
|
(40,145) |
|
|
936,949 |
|
|
|
|||||
|
Total comprehensive income for the year, net of tax |
|
85,196,227 |
|
|
60,131,596 |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Attributable to: |
|
|
|
|
|
|
|
|
|||||
|
Equity holders of the parent |
|
85,062,367 |
|
|
60,071,258 |
|
|
|
|||||
|
Non-controlling interest |
|
133,860 |
|
|
60,338 |
|
|
|
|||||
|
Total comprehensive income for the year, net of tax |
|
85,196,227 |
|
|
60,131,596 |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Consolidated Statement of Financial Position as at December 31, 2025 |
|
||||||||||||
|
|
|
Notes |
Dec. 31, 2025 |
|
Dec. 31, 2024 |
|
|||||||
|
|
|
|
|
|
|
||||||||
|
|
Assets |
|
|
|
|
|
|||||||
|
|
Cash and cash equivalents |
13 |
20,002,406 |
|
21,752,997 |
|
|||||||
|
|
Balances at the central bank |
14 |
68,874,046 |
|
114,778,023 |
|
|||||||
|
|
Due from banks |
15 |
135,236,549 |
|
270,829,834 |
|
|||||||
|
|
Loans and advances to banks, net |
16 |
34,440,770 |
|
9,555,410 |
|
|||||||
|
|
Loans and advances to customers, net |
17 |
507,953,766 |
|
343,542,674 |
|
|||||||
|
|
Financial Assets at fair value through profit or loss |
20 |
3,173,539 |
|
380,769 |
|
|||||||
|
|
Derivative financial instruments |
18 |
620,349 |
|
819,711 |
|
|||||||
|
|
Financial Assets at fair value through Other comprehensive income |
20 |
373,747,694 |
|
234,694,966 |
|
|||||||
|
|
Financial Assets at amortized cost |
20 |
236,672,175 |
|
168,118,219 |
|
|||||||
|
|
Right of use assets |
24 |
2,469,076 |
|
1,301,850 |
|
|||||||
|
|
Investments in associates |
22 |
45,210 |
|
98,193 |
|
|||||||
|
|
Non-current-assets held for sale |
43 |
182,827 |
|
- |
|
|||||||
|
|
Other assets |
23 |
54,040,912 |
|
44,282,773 |
|
|||||||
|
|
Deferred tax assets |
10.2 |
2,545,498 |
|
2,685,330 |
|
|||||||
|
|
Property and equipment |
24 |
5,481,682 |
|
3,997,929 |
|
|||||||
|
|
Total assets |
|
1,445,486,499 |
|
1,216,838,678 |
|
|||||||
|
|
Liabilities and equity |
|
|
|
|
|
|||||||
|
|
Liabilities |
|
|
|
|
|
|||||||
|
|
Due to banks |
25 |
3,353,746 |
|
2,034,885 |
|
|||||||
|
|
Due to customers |
26 |
1,110,395,693 |
|
972,595,958 |
|
|||||||
|
|
Lease liabilities |
24 |
2,526,481 |
|
1,425,604 |
|
|||||||
|
|
Derivative financial instruments |
18 |
137,802 |
|
100,571 |
|
|||||||
|
|
Non-current-liabilities held for sale |
44 |
53,860 |
|
1,397 |
|
|||||||
|
|
Issued debt instruments |
19 |
4,761,558 |
|
5,067,781 |
|
|||||||
|
|
Other liabilities |
28 |
33,144,838 |
|
27,725,569 |
|
|||||||
|
|
Current Tax liability |
|
20,570,313 |
|
18,327,968 |
|
|||||||
|
|
Other loans |
27 |
30,471,499 |
|
23,962,389 |
|
|||||||
|
|
Provisions |
29 |
15,644,651 |
|
18,623,634 |
|
|||||||
|
|
Total liabilities |
|
1,221,060,441 |
|
1,069,865,756 |
|
|||||||
|
|
Equity attributable to equity holders of parent |
|
|
|
|
|
|||||||
|
|
Issued and paid in capital |
30 |
33,779,361 |
|
30,431,580 |
|
|||||||
|
|
Reserves |
31 |
105,020,603 |
|
62,899,966 |
|
|||||||
|
|
Reserve for employee stock ownership plan (ESOP) |
31.9 |
2,343,532 |
|
1,868,235 |
|
|||||||
|
|
Retained earnings |
31.8 |
83,254,686 |
|
51,590,097 |
|
|||||||
|
|
Total equity attributable to equity holders of the parent |
|
224,398,182 |
|
146,789,878 |
|
|||||||
|
|
Total equity attributable to non-controlling interest |
39 |
27,876 |
|
183,044 |
|
|||||||
|
|
Total equity |
|
224,426,058 |
|
146,972,922 |
|
|||||||
|
|
Total liabilities and equity |
|
1,445,486,499 |
|
1,216,838,678 |
|
|||||||
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|||||||
|
|
The accompanying notes from 1 to 46 form an integral part of these consolidated financial statements. |
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|||||||
|
|
Islam Zekry |
|
Hisham Ezz Al-Arab |
|
|||||||||
|
|
Group CFO & Executive Board Member |
|
CEO & Executive Board Member |
|
|||||||||
|
|
9-Feb-2026 |
|
9-Feb-2026 |
|
|||||||||
|
Consolidated statement of changes in equity for the year ended December 31, 2025 |
|
|
|
|
|
|
|
|
|
||||||||||
|
Dec. 31, 2025 |
Issued and paid-up capital |
Legal reserve |
General reserve |
General risk reserve |
Special reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders' Equity |
Non-controlling interests |
Total |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Beginning balance |
30,431,580 |
6,208,674 |
62,422,792 |
1,550,906 |
- |
(670,972) |
22,818 |
(7,789,896) |
17,924 |
51,590,097 |
1,868,235 |
1,137,720 |
146,789,878 |
183,044 |
146,972,922 |
||||
|
Total comprehensive income net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net profit of the year |
- |
- |
- |
- |
- |
- |
- |
- |
- |
75,460,219 |
- |
- |
75,460,219 |
19,963 |
75,480,182 |
||||
|
Transferred to general risk reserve |
- |
- |
- |
26,186 |
- |
- |
- |
- |
- |
(26,186) |
- |
- |
- |
- |
- |
||||
|
Net unrealised gain/(loss) on financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
- |
9,937,984 |
- |
- |
- |
- |
9,937,984 |
113,897 |
10,051,881 |
||||
|
Transferred (from) to banking risk reserve
|
- |
- |
- |
- |
- |
- |
- |
- |
(2,628) |
2,628 |
- |
- |
- |
- |
- |
||||
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI
|
- |
- |
- |
- |
- |
- |
- |
(40,145) |
- |
- |
- |
- |
(40,145) |
- |
(40,145) |
||||
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(295,691) |
(295,691) |
- |
(295,691) |
||||
|
Total comprehensive income |
- |
- |
- |
26,186 |
- |
- |
- |
9,897,839 |
(2,628) |
75,436,661 |
- |
(295,691) |
85,062,367 |
133,860 |
85,196,227 |
||||
|
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI
|
- |
- |
- |
- |
- |
- |
- |
(111,370) |
- |
111,370 |
- |
- |
- |
- |
- |
||||
|
Transferred to reserves
|
- |
2,771,284 |
19,758,610 |
- |
- |
- |
2,246 |
- |
- |
(21,744,828) |
(787,312) |
- |
- |
- |
- |
||||
|
Transferred from net profit to special reserve
|
- |
- |
- |
- |
13,145,012 |
- |
- |
- |
- |
(13,145,012) |
- |
- |
- |
- |
- |
||||
|
Dividend paid
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
(8,993,602) |
- |
- |
(8,993,602) |
(289,028) |
(9,282,630) |
||||
|
Cost of employee's stock ownership plan (ESOP)
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
1,262,609 |
- |
1,262,609 |
- |
1,262,609 |
||||
|
Capital increase |
3,347,781 |
- |
(3,070,851) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
276,930 |
- |
276,930 |
||||
|
Balance at the end of the year |
33,779,361 |
8,979,958 |
79,110,551 |
1,577,092 |
13,145,012 |
(670,972) |
25,064 |
1,996,573 |
15,296 |
83,254,686 |
2,343,532 |
842,029 |
224,398,182 |
27,876 |
224,426,058 |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Consolidated statement of changes in equity for the year ended December 31, 2024 |
|
|
|
|
|
|
|
|
|
||||||||||
|
Dec. 31, 2024 |
Issued and paid-up capital |
Legal reserve |
General reserve |
General risk reserve |
Special reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders' Equity |
Non-controlling interests |
Total |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Beginning balance |
30,195,010 |
4,770,354 |
39,840,707 |
1,550,906 |
- |
(670,972) |
21,155 |
(17,313,043) |
15,230 |
27,442,585 |
1,486,010 |
148,353 |
87,486,295 |
160,073 |
87,646,368 |
||||
|
Total comprehensive income net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net profit of the year
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
49,558,744 |
- |
- |
49,558,744 |
60,338 |
49,619,082 |
||||
|
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI
|
- |
- |
- |
- |
- |
- |
- |
(370,224) |
- |
- |
- |
- |
(370,224) |
- |
(370,224) |
||||
|
Net unrealised gain/(loss) on financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
- |
8,956,422 |
- |
- |
- |
- |
8,956,422 |
- |
8,956,422 |
||||
|
Transferred (from) to banking risk reserve
|
- |
- |
- |
- |
- |
- |
- |
- |
2,694 |
(2,694) |
- |
- |
- |
- |
- |
||||
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI
|
- |
- |
- |
- |
- |
- |
- |
936,949 |
- |
- |
- |
- |
936,949 |
- |
936,949 |
||||
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
989,367 |
989,367 |
- |
989,367 |
||||
|
Total comprehensive income |
- |
- |
- |
- |
- |
- |
- |
9,523,147 |
2,694 |
49,556,050 |
- |
989,367 |
60,071,258 |
60,338 |
60,131,596 |
||||
|
Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI |
- |
- |
- |
- |
- |
- |
- |
- |
- |
370,224 |
- |
- |
370,224 |
- |
370,224 |
||||
|
Transferred to reserves |
- |
1,438,320 |
22,582,085 |
- |
- |
- |
1,663 |
- |
- |
(23,398,943) |
(623,125) |
- |
- |
- |
- |
||||
|
Dividend paid |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(2,379,819) |
- |
- |
(2,379,819) |
(37,367) |
(2,417,186) |
||||
|
Cost of employee's stock ownership plan (ESOP)
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
1,005,350 |
- |
1,005,350 |
- |
1,005,350 |
||||
|
Capital increase |
236,570 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
236,570 |
- |
236,570 |
||||
|
Balance at the end of the year |
30,431,580 |
6,208,674 |
62,422,792 |
1,550,906 |
- |
(670,972) |
22,818 |
(7,789,896) |
17,924 |
51,590,097 |
1,868,235 |
1,137,720 |
146,789,878 |
183,044 |
146,972,922 |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 |
|
||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
Notes |
Dec. 31, 2025 |
|
Dec. 31, 2024 |
|
||||||||||||||
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Cash flow from operating activities |
|
|
|
|
|
||||||||||||||
|
Profit before income tax |
|
104,803,388 |
|
71,498,028 |
|
||||||||||||||
|
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
|
|
||||||||||||||
|
Fixed assets depreciation |
|
2,307,297 |
|
1,414,920 |
|
||||||||||||||
|
Impairment charge for credit losses (Loans and advances to customers) |
|
(9,101,206) |
|
4,768,107 |
|
||||||||||||||
|
Net charge/release for other provisions |
|
(2,893,591) |
|
3,363,525 |
|
||||||||||||||
|
Impairment release/charge for credit losses (due from banks) |
|
137,399 |
|
(341) |
|
||||||||||||||
|
Impairment release/charge for credit losses (financial investments) |
|
146,649 |
|
(243,947) |
|
||||||||||||||
|
Impairment release/charge for other assets |
|
- |
|
37,939 |
|
||||||||||||||
|
Exchange revaluation differences for financial assets at fair value through OCI and AC |
|
5,137,808 |
|
(21,026,044) |
|
||||||||||||||
|
Utilization of other provisions |
|
(7,467) |
|
(9,586) |
|
||||||||||||||
|
Revaluation differences impairment charge for due from banks |
|
(8,542) |
|
2,008 |
|
||||||||||||||
|
Exchange revaluation differences of other provisions |
|
(77,925) |
|
4,173,699 |
|
||||||||||||||
|
Revaluation differences impairment charge for Financial Assets at Amortized cost |
|
(18,527) |
|
119,504 |
|
||||||||||||||
|
Profits from selling property, plant and equipment |
|
(13,005) |
|
(2,246) |
|
||||||||||||||
|
Profits/losses from selling financial investments at fair value through OCI |
|
(498,433) |
|
(459,337) |
|
||||||||||||||
|
Revaluation differences impairment charge for Financial Assets at Fair value through OCI |
|
(242,624) |
|
1,329,905 |
|
||||||||||||||
|
Shares based payments |
|
1,262,609 |
|
1,005,350 |
|
||||||||||||||
|
Profits/losses from selling investments in associates |
|
(277,408) |
|
- |
|
||||||||||||||
|
Net share of results of associates |
|
(10,512) |
|
17,786 |
|
||||||||||||||
|
|
|
100,645,910 |
|
65,989,270 |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Change in: |
|
|
|
|
|
||||||||||||||
|
Due from banks |
|
98,091,341 |
|
(111,192,809) |
|
||||||||||||||
|
Financial assets at fair value through profit or loss |
|
(2,792,770) |
|
(74,394) |
|
||||||||||||||
|
Derivative financial instruments |
|
(88,654) |
|
490,593 |
|
||||||||||||||
|
Loans and advances to banks and customers |
|
(180,420,385) |
|
(122,049,597) |
|
||||||||||||||
|
Other assets |
|
(5,289,420) |
|
(22,078,200) |
|
||||||||||||||
|
Non-current assets held for sale |
|
(182,827) |
|
- |
|
||||||||||||||
|
Non-current liabilities held for sale |
|
52,463 |
|
524 |
|
||||||||||||||
|
Due to banks |
|
1,318,861 |
|
(10,423,118) |
|
||||||||||||||
|
Due to customers |
|
137,799,735 |
|
295,358,479 |
|
||||||||||||||
|
Current income tax obligations paid |
|
(27,080,861) |
|
(5,220,965) |
|
||||||||||||||
|
Other liabilities |
|
7,489,703 |
|
5,788,117 |
|
||||||||||||||
|
Net cash generated from operating activities |
|
129,543,096 |
|
96,587,900 |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Cash flow from investing activities |
|
|
|
|
|
||||||||||||||
|
Proceeds from sale of investments in associates |
|
339,920 |
|
11,956 |
|
||||||||||||||
|
Payments for purchases of property, equipment and branches construction |
|
(7,930,273) |
|
(6,707,018) |
|
||||||||||||||
|
Proceeds from selling property and equipment |
|
13,005 |
|
2,246 |
|
||||||||||||||
|
Proceeds from redemption of financial assets at amortized cost |
|
21,689,390 |
|
2,028,180 |
|
||||||||||||||
|
Payments for purchases of financial assets at amortized cost |
|
(90,488,312) |
|
(129,153,136) |
|
||||||||||||||
|
Payments for purchases of financial assets at fair value through OCI |
|
(263,771,830) |
|
(113,445,585) |
|
||||||||||||||
|
Proceeds from selling financial assets at fair value through OCI |
|
127,867,188 |
|
140,381,225 |
|
||||||||||||||
|
Net cash generated from (used in) investing activities |
|
(212,280,912) |
|
(106,882,132) |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
||||||||||||||||||
|
Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 (Cont.) |
|
||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
Notes |
Dec. 31, 2025 |
|
Dec. 31, 2024 |
|
||||||||||||||
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Cash flow from financing activities |
|
|
|
|
|
||||||||||||||
|
Other loans |
|
6,509,110 |
|
11,478,482 |
|
||||||||||||||
|
Other loans - new loans obtained in the year |
|
8,701,546 |
|
3,835,016 |
|
||||||||||||||
|
Other loans - loans repaid in the year |
|
(789,099) |
|
(243,015) |
|
||||||||||||||
|
Other loans - movement in foreign exchange rate |
|
(1,403,337) |
|
7,886,481 |
|
||||||||||||||
|
Dividends |
|
(9,282,630) |
|
(2,379,819) |
|
||||||||||||||
|
Issued debt instruments |
|
(306,223) |
|
1,994,432 |
|
||||||||||||||
|
Cash payments for lease (principal and interest) |
|
(391,907) |
|
(501,724) |
|
||||||||||||||
|
Capital increase |
|
276,930 |
|
236,570 |
|
||||||||||||||
|
Net cash generated from (used in) financing activities |
|
(3,194,720) |
|
10,827,941 |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Net increase (decrease) in cash and cash equivalent during the year |
|
(85,932,536) |
|
533,709 |
|
||||||||||||||
|
Beginning balance of cash and cash equivalent |
|
226,475,092 |
|
225,941,383 |
|
||||||||||||||
|
Cash and cash equivalent at the end of the year |
|
140,542,556 |
|
226,475,092 |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
Cash and cash equivalent at the end of the year |
|
|
|
|
|
||||||||||||||
|
Cash and cash equivalents |
13 |
20,002,406 |
|
21,752,997 |
|
||||||||||||||
|
Due from banks with maturities of 3 months or less |
15 |
120,525,563 |
|
203,103,430 |
|
||||||||||||||
|
Treasury bills and other governmental notes with maturities of three months or less |
|
14,587 |
|
1,618,665 |
|
||||||||||||||
|
Total cash and cash equivalent |
32 |
140,542,556 |
|
226,475,092 |
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.